[Discontinuation or tapering strategies of biologics in rheumatoid arthritis in remission]
Abstract
The arrival of new drugs and new therapeutic strategies allowed to reach sustained remission in an increasing number of patients with rheumatoid arthritis. The study of biologic disease-modifying anti-rheumatic drugs (bDMARDs) adaptation strategies is a need to optimize the benefit/risk balance and …
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
humans
pubmed abstract
nih
national institutes of health
national library of medicine
Recurrence
Remission Induction
dose-response relationship
drug
arthritis
rheumatoid / drug therapy*
practice patterns
antirheumatic agents / administration & dosage*
pmid:28161110
doi:10.1016/j.revmed.2016.12.014
a mallick
b fautrel
j sibilia
biological factors / administration & dosage
biological products / administration & dosage*
physicians'
withholding treatment* / standards
Access
Citation
ID:
117028
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
117028
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet